Patents Assigned to Mitsubishi Tanabe Pharmaceutical Company
  • Compositions for treating or preventing vasomotor symptoms
    Patent number: 10993939
    Abstract: The present disclosure is directed to compositions and methods for treating or preventing vasomotor symptoms such as hot flashes, comprising a Transient Receptor Potential Melastatin 8 (TRPM8) antagonist and administering a TRPM8 antagonist, respectively.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: May 4, 2021
    Assignee: Mitsubishi Tanabe Pharmaceutical Company
    Inventor: Joseph M. Palumbo